Aura Biosciences, Inc. - Common Stock (AURA)

CUSIP: 05153U107

Q1 2022 13F Holders as of 31 Mar 2022

Holder snapshot 6 signals
Share change
+410,352
SEC-reported price per share
$22.00
Number of holders
34
Value change
+$9,092,301
Number of buys
17
Number of sells
11
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
103,767,237

Security key

05153U107

Report period

Q1 2022

Institutions

34

Top holders

10

Ownership snapshot

Top reported holders of AURA - Aura Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Medicxi Ventures Manageme...
Disclosed value leader
Matrix Capital Management...
Comparable rows
0/15
Latest evidence
31 Dec 2021
13F 3/4/5 Highest disclosed value: $69,837,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Matrix Capital Management Company, LP has the largest disclosed position value at $69.84M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Matrix Capital Management Company, LP's linked filing trail.
Disclosed position value Top 5
Medicxi Ventures Management (Jers... $51.62M
Matrix Capital Management Company... $69.84M
CITADEL ADVISORS LLC $37.32M
ADAGE CAPITAL PARTNERS GP, L.L.C. $21.32M
Rock Springs Capital Management LP $17.12M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Medicxi Ventures Management (Jersey) Ltd
13F 3/4/5
Company · 10%+ Owner
—
denominator unverified
$51,617,000
3,039,892 shares
— 31 Dec 2021
Matrix Capital Management Company, LP
13F
Company
13F
—
denominator unverified
$69,837,000
4,112,870 shares
— 31 Dec 2021
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$37,318,000
2,315,102 shares
— 31 Dec 2021
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
—
denominator unverified
$21,318,000
1,255,480 shares
— 31 Dec 2021
Rock Springs Capital Management LP
13F
Company
13F
—
denominator unverified
$17,118,000
1,008,114 shares
— 31 Dec 2021
FMR LLC
13F
Company
13F
—
denominator unverified
$8,003,000
471,300 shares
— 31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
34
Shares
13,702,730
Rows available
34
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q4 2025 Across Filers

Q4 2025 holders
116
Q1 2022 holders
34
Holder diff
-82
Investor Q4 2025 Shares Q1 2022 Shares Share Diff Share Chg % Q4 2025 value Q1 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .